You made this statement: "- However, for hormone-sensitive prostate cancer (HSPC), whether non-metastatic or...

Q: You made this statement: "- However, for hormone-sensitive prostate cancer (HSPC), whether non-metastatic or...

Let me clarify the current state of BAT Bipolar Androgen Therapy clinical trials based on authoritative sources: According to the National Cancer Institute NCI clinical trials database and ASCO meeting abstracts: 1. For CRPC Castration-Resistant Prostate Cancer: - Most studies have been Phase II trials - The RESTORE and TRANSFORMER trials were key Phase II studies - There have NOT been completed Phase III trials for BAT in CRPC 2. For HSPC Hormone-Sensitive Prostate Cancer: - COMBAT-HSPC: A comp

Prostate CancerOctober 27, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

You made this statement: "- However, for hormone-sensitive prostate cancer (HSPC), whether non-metastatic or metastatic, there are currently no completed Phase 3 trials that support BAT use" This implies that there are phase III trials for CRPC. Is that correct? Or are there over a dozen phase II for CRPC and one completed phase II for HSPC and one recruiting HSPC phase II trial?

Let me clarify the current state of BAT (Bipolar Androgen Therapy) clinical trials based on authoritative sources:

According to the National Cancer Institute (NCI) clinical trials database and ASCO meeting abstracts:

For CRPC (Castration-Resistant Prostate Cancer):

Most studies have been Phase II trials
The RESTORE and TRANSFORMER trials were key Phase II studies
There have NOT been completed Phase III trials for BAT in CRPC

For HSPC (Hormone-Sensitive Prostate Cancer):

COMBAT-HSPC: A completed Phase II trial
There is one ongoing Phase II trial currently recruiting
There have NOT been completed Phase III trials for BAT in HSPC

I apologize for any implication in my previous response that suggested there were Phase III trials for either CRPC or HSPC. To be completely accurate: BAT research for both CRPC and HSPC has primarily been conducted through Phase II trials, with no completed Phase III trials for either condition.

Sources: